Merck & Company Inc (MRK)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 28,126,000 28,717,000 28,778,000 29,139,000 29,510,000 29,379,000 29,096,000 29,173,000 30,451,000 29,693,000 29,138,000 27,652,000 26,529,000 30,232,000 30,256,000 30,439,000 29,776,000 26,138,000 27,476,000 28,046,000
Payables US$ in thousands 4,079,000 3,586,000 3,519,000 3,514,000 3,922,000 3,509,000 3,442,000 3,680,000 4,264,000 3,371,000 3,482,000 3,715,000 4,609,000 3,366,000 3,897,000 4,034,000 4,327,000 3,744,000 3,448,000 3,572,000
Payables turnover 6.90 8.01 8.18 8.29 7.52 8.37 8.45 7.93 7.14 8.81 8.37 7.44 5.76 8.98 7.76 7.55 6.88 6.98 7.97 7.85

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $28,126,000K ÷ $4,079,000K
= 6.90

The payables turnover ratio for Merck & Company Inc has shown fluctuations over the past few years, ranging from a low of 5.76 to a high of 8.98. Generally, a higher payables turnover ratio indicates that the company is paying its suppliers more frequently and efficiently.

In the most recent period, the payables turnover ratio was 6.90, which suggests that Merck & Company Inc took longer to pay its suppliers compared to the prior period. It is important to assess the trend over time and compare it to industry benchmarks to understand if the company's payables management practices are improving or deteriorating.

Overall, the payables turnover ratio provides insights into how effectively the company is managing its accounts payable and cash flow. A consistent and stable ratio over time is typically favorable as it indicates good relationships with suppliers and efficient working capital management.


See also:

Merck & Company Inc Payables Turnover (Quarterly Data)